Hjorth, C. F., Nielsen, A. S., Sørensen, H. T., Lash, T. L., Damkier, P., Hamilton-Dutoit, S., & Cronin-Fenton, D. (2018). Multi-drug resistance protein 2 (MRP2) expression, adjuvant tamoxifen therapy, and risk of breast cancer recurrence: A Danish population-based nested case-control study. Acta Oncol.
Styl ChicagoHjorth, Cathrine F., Anja S. Nielsen, Henrik T. Sørensen, Timothy L. Lash, Per Damkier, Stephen Hamilton-Dutoit, a Deirdre Cronin-Fenton. "Multi-drug Resistance Protein 2 (MRP2) Expression, Adjuvant Tamoxifen Therapy, and Risk of Breast Cancer Recurrence: A Danish Population-based Nested Case-control Study." Acta Oncol 2018.
Citace podle MLAHjorth, Cathrine F., et al. "Multi-drug Resistance Protein 2 (MRP2) Expression, Adjuvant Tamoxifen Therapy, and Risk of Breast Cancer Recurrence: A Danish Population-based Nested Case-control Study." Acta Oncol 2018.